A CXC motif ligand 10 polymorphism as a marker to predict severity of graves' disease

Thyroid

Volumn 20, Issue 3, 2010, Pages 343-345

  Brück, Patrick ^a   Bartsch, Wiebke ^b   Sadet, Dilek ^b   Penna Martinez, Marissa ^b   Kurylowicz, Alina ^c   Bednarczuk, Tomasz ^c   Robbers, Inka ^b   Paunkovic, Jane ^d   Böhme, Angelika ^b   Badenhoop, Klaus ^b   Ramos Lopez, Elizabeth ^b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d Medical Center Zajecar   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; THYROTROPIN RECEPTOR ANTIBODY;

ADDISON DISEASE; ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EYE DISEASE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GERMANY; GRAVES DISEASE; HAPLOTYPE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; POLAND; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; RHEUMATOID ARTHRITIS; SERBIA; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CRISIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOKINE CXCL10; CHILD; FEMALE; GENETIC MARKERS; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 77649330594     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0222     Document Type: Letter

References (22)

1. Weetman AP 2000 Graves' disease. N Engl J Med 343:1236-1248.
2. Aniszewski JP, Valyasevi RW, Bahn RS 2000 Relationship between disease duration and predominant orbital T cell subset in Graves' disease. J Clin Endocrinol Metab 85:776-780.
3. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF 2003 TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) 58:280-287.
4. Weetman AP 2004 Cellular immune response in autoimmune thyroid disease. Clin Endocrinol (Oxf) 61:405-413.
5. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F 1998 Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-134.
6. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A 1998 Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875-883.
7. Franciotta D, Martino G, Zardini E, Furlan R, Bergamaschi R, Andreoni L, Cosi V 2001 Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol 115:192-198.
8. Nicoletti F, Conget I, Di Mauro M, Di Marco R, Mazzarino MC, Bendtzen K, Messina A, Gomis R 2002 Serum concentrations of the interferon-gamma-inducible chemokin IP-10=CXCL10 are augmented in both newly diagnosed type 1 diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110.
9. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Buonamano A, Ferrannini E, Serio M 2004 High levels of circulating CXCL10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89:5496-5499.
10. García-López MA, Sancho D, Sánchez-Madrid F, Marazuela M 2001 Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+lymphocytes. J Clin Endocrinol Metab 86:5008-5016.
11. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman AP 2003 Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 59:207-213.
12. Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, Buonamano A, Milani S, Vitti P, Chiovato L, Tonacchera M, Bellastella A, Serio M 2002 Expression of IP-10=CXCL10 and Mig=CXCL9 in the thyroid and increased serum levels of IP-10=CXCL10 in the serum of subjects with recent onset Graves' disease. Am J Pathol 161:195-206.
13. Rotondi M, Lazzeri E, Romagnani P, Serio M 2003 Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 26:177-180.
14. Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Romagnani P, Grosso M, Ferrannini E, Serio M 2006 Increased serum CXCL10 in Graves' disease or autoimmune thyreoditis is associated with hyper -or hypothyreoidism per se, but is specifically sustained by the autoimmune, inflammatory process. Eur J Endocrinol 154:651-658.
15. Galimberti D, Scalabrini D, Fenoglio C, Comi C, De Riz M, Venturelli E, Lovati C, Mariani C, Monaco F, Bresolin N, Scarpini E 2007 CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course. Eur J Neurol 14:162-167.
16. Venturelli E, Galimberti D, Fenoglio C, Lovati C, Finazzi D, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Forloni G, Bresolin N, Scarpini E 2006 Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease. Neurosci Lett 404:217-221.
17. Zhang J, Noguchi E, Migita O, Yokouchi Y, Nakayama J, Shibasaki M, Arinami T 2005 Association of a haplotype block spanning SDAD1 gene and CXC chemokine genes with allergic rhinitis. J Allergy Clin Immunol 115:548-554.
18. Brück P, Bartsch W, Penna-Martinez M, Kahles H, Seidl C, Böhme A, Badenhoop K, Ramos-Lopez E 2009 Hum Immunol 70:552-555.
19. Fujii H, Shimada Y, Hasegawa M, Takehara K, Sato S 2004 Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. J Dermatol Sci 35:43-51.
20. Bugeja MJ, Booth DR, Bennetts BH, Heard RNS, Stewart GJ 2006 An investigation of polymorphisms in the 4q13.3-21.1 CXC chemokin gene cluster for association with multiple sclerosis in Australians. Mult Scler 12:710-722
21. Bartalena L, Pinchera A, Marcocci C 2000 Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 21:168-199.
22. Bednarczuk T, Gopinath B, Ploski R, Wall JR 2007 Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 67:3-19.